Skip to content

Correlation Between Expression of Hormonal Receptors, Clinical Data, and Methylation Profile in Meningiomas (MethylRH-M)

Correlation Between Expression of Hormonal Receptors, Clinical Data, and Methylation Profile in Meningiomas

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06278103
Acronym
MethylRH-M
Enrollment
180
Registered
2024-02-26
Start date
2000-01-01
Completion date
2024-09-01
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meningioma

Keywords

Meningioma, Hormonal receptors

Brief summary

This research aims to explore the relationship between hormonal receptor expression and the clinical and histopathological characteristics of meningiomas. The underlying hypothesis is that hormonal receptor expression, as well as the methylation profile of their gene promoters, are associated with specific aspects of meningiomas and patients' clinical outcomes. The main objective is to study the correlation between the immunohistochemical expression of hormonal receptors and clinicopathological data. The secondary objectif is to study the correlation between the methylation profile of hormonal receptor gene promoters and their immunohistochemical expression.

Interventions

None listed

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who underwent surgery for a meningioma at the University Hospital of Nancy between 2000 and 2022.

Exclusion criteria

* Patients who did not express their consent to participate in the study. * Patients with grade 2 or 3 meningiomas whose samples are no longer available or in insufficient quantity to perform an immunohistochemical study. * Patients with grade 1 meningiomas not selected by randomization. * Patients withdrawing their consent.

Design outcomes

Primary

MeasureTime frameDescription
immunohistochemical expression of different hormonal receptorsup to 24 years after surgeryEvaluated on FFPE sections

Secondary

MeasureTime frameDescription
methylation profile of the promoters of hormonal receptor genesup to 24 years after surgeryMethylation profile established from frozen tissue.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026